Showing results (31-40 of 155) with videos related to
Sort By:
Pageof 16
Internal Medicine (Tokyo, Japan)|November 18, 2016
Cases with Refractory Ascites and a Delayed Response to TolvaptanSatoru Hagiwara, Naoshi Nishida, Hirokazu Chishina, et al.Science (New York, N.Y.)|July 7, 2007
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionWillscott E Naugler, Toshiharu Sakurai, Sunhwa Kim, et al.British Journal of Haematology|November 12, 2005
Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitopeMutsuko Ohnishi, Toshiharu Sakurai, Yuji Heike, et al.The Journal of Biological Chemistry|January 15, 2003
MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activityToshikazu Nagao, Hiroaki Higashitsuji, Kohsuke Nonoguchi, et al.Digestive Diseases and Sciences|March 20, 2013
Association of gankyrin and stemness factor expression in human colorectal cancerHiromasa Mine, Toshiharu Sakurai, Hiroshi Kashida, et al.Biochemical and Biophysical Research Communications|November 7, 2017
Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in miceHiroki Nishiyama, Tomoyuki Nagai, Masatoshi Kudo, et al.Cancer Science|January 23, 2015
Cold-inducible RNA-binding protein promotes the development of liver cancerToshiharu Sakurai, Norihisa Yada, Tomohiro Watanabe, et al.Biochemical and Biophysical Research Communications|February 5, 2013
Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1Yu Liu, Hiroaki Higashitsuji, Hisako Higashitsuji, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progressionShoko Nakamura, Tomonori Yaguchi, Naoshi Kawamura, et al.FEBS Letters|February 28, 2004
Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomasKazuhisa Gotoh, Kohsuke Nonoguchi, Hiroaki Higashitsuji, et al.Pageof 16